100 related articles for article (PubMed ID: 26088413)
21. [Expression of methylthioadenosine phosphorylase (MTAP) gene and demethylation of its promoter in human colorectal cancer].
Dou JX; Zhang WD; Li WT; Li HL; Cai XS; Liu J
Ai Zheng; 2009 Apr; 28(4):390-4. PubMed ID: 19622299
[TBL] [Abstract][Full Text] [Related]
22. Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapy.
Marcé S; Balagué O; Colomo L; Martinez A; Höller S; Villamor N; Bosch F; Ott G; Rosenwald A; Leoni L; Esteller M; Fraga MF; Montserrat E; Colomer D; Campo E
Clin Cancer Res; 2006 Jun; 12(12):3754-61. PubMed ID: 16778103
[TBL] [Abstract][Full Text] [Related]
23. Methylthioadenosine phosphorylase cDNA transfection alters sensitivity to depletion of purine and methionine in A549 lung cancer cells.
Hori H; Tran P; Carrera CJ; Hori Y; Rosenbach MD; Carson DA; Nobori T
Cancer Res; 1996 Dec; 56(24):5653-8. PubMed ID: 8971171
[TBL] [Abstract][Full Text] [Related]
24. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.
Hellerbrand C; Mühlbauer M; Wallner S; Schuierer M; Behrmann I; Bataille F; Weiss T; Schölmerich J; Bosserhoff AK
Carcinogenesis; 2006 Jan; 27(1):64-72. PubMed ID: 16081515
[TBL] [Abstract][Full Text] [Related]
25. Reliability assessment of methylthioadenosine phosphorylase immunohistochemistry as a surrogate biomarker for CDKN2A homozygous deletion in adult-type IDH-mutant diffuse gliomas.
Gundogdu F; Babaoglu B; Soylemezoglu F
J Neuropathol Exp Neurol; 2024 Jan; 83(2):107-114. PubMed ID: 38109891
[TBL] [Abstract][Full Text] [Related]
26. Prognostic role of urokinase-type plasminogen activator in human gliomas.
Hsu DW; Efird JT; Hedley-Whyte ET
Am J Pathol; 1995 Jul; 147(1):114-23. PubMed ID: 7604873
[TBL] [Abstract][Full Text] [Related]
27. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
Schmid M; Malicki D; Nobori T; Rosenbach MD; Campbell K; Carson DA; Carrera CJ
Oncogene; 1998 Nov; 17(20):2669-75. PubMed ID: 9840931
[TBL] [Abstract][Full Text] [Related]
28. Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy.
Chen ZH; Zhang H; Savarese TM
Cancer Res; 1996 Mar; 56(5):1083-90. PubMed ID: 8640765
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of methylthioadenosin phosphorylase by homozygous deletion in gastric carcinoma.
Kim J; Kim MA; Min SY; Jee CD; Lee HE; Kim WH
Genes Chromosomes Cancer; 2011 Jun; 50(6):421-33. PubMed ID: 21412930
[TBL] [Abstract][Full Text] [Related]
30. A potential predictive marker for response to interferon in malignant melanoma.
Wild PJ; Meyer S; Landthaler M; Hofstaedter F; Bosserhoff AK
J Dtsch Dermatol Ges; 2007 Jun; 5(6):456-9. PubMed ID: 17537037
[TBL] [Abstract][Full Text] [Related]
31. Presence of methylthioadenosine phosphorylase (MTAP) in hematopoietic stem/progenitor cells: its therapeutic implication for MTAP (-) malignancies.
Yu J; Batova A; Shao L; Carrera CJ; Yu AL
Clin Cancer Res; 1997 Mar; 3(3):433-8. PubMed ID: 9815702
[TBL] [Abstract][Full Text] [Related]
32. Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers.
Ngoi NYL; Tang TY; Gaspar CF; Pavlick DC; Buchold GM; Scholefield EL; Parimi V; Huang RSP; Janovitz T; Danziger N; Levy MA; Pant S; De Armas AD; Kumpula D; Ross JS; Javle M; Rodon Ahnert J
Oncologist; 2024 Jun; 29(6):493-503. PubMed ID: 38330461
[TBL] [Abstract][Full Text] [Related]
33. Methylthioadenosine phosphorylase (MTAP) in hearing: gene disruption by chromosomal rearrangement in a hearing impaired individual and model organism analysis.
Williamson RE; Darrow KN; Michaud S; Jacobs JS; Jones MC; Eberl DF; Maas RL; Liberman MC; Morton CC
Am J Med Genet A; 2007 Jul; 143A(14):1630-9. PubMed ID: 17534888
[TBL] [Abstract][Full Text] [Related]
34. Predictive factors for early symptomatic recurrence in pilocytic astrocytoma: does angiogenesis have a role to play?
Kurwale NS; Suri V; Suri A; Sarkar C; Gupta DK; Sharma BS; Mahapatra AK
J Clin Neurosci; 2011 Apr; 18(4):472-7. PubMed ID: 21292490
[TBL] [Abstract][Full Text] [Related]
35. Expression of MTAP inhibits tumor-related phenotypes in HT1080 cells via a mechanism unrelated to its enzymatic function.
Tang B; Kadariya Y; Chen Y; Slifker M; Kruger WD
G3 (Bethesda); 2014 Nov; 5(1):35-44. PubMed ID: 25387827
[TBL] [Abstract][Full Text] [Related]
36. Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin.
Sharma MK; Mansur DB; Reifenberger G; Perry A; Leonard JR; Aldape KD; Albin MG; Emnett RJ; Loeser S; Watson MA; Nagarajan R; Gutmann DH
Cancer Res; 2007 Feb; 67(3):890-900. PubMed ID: 17283119
[TBL] [Abstract][Full Text] [Related]
37. [Detection of MTAP protein and gene expression in non-small cell lung cancer].
Li S; Zhang Y; Li H; Ding B
Zhongguo Fei Ai Za Zhi; 2011 Feb; 14(2):151-5. PubMed ID: 21342647
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy targeting methylthioadenosine phosphorylase (MTAP) deficiency in adult T cell leukemia (ATL).
Harasawa H; Yamada Y; Kudoh M; Sugahara K; Soda H; Hirakata Y; Sasaki H; Ikeda S; Matsuo T; Tomonaga M; Nobori T; Kamihira S
Leukemia; 2002 Sep; 16(9):1799-807. PubMed ID: 12200696
[TBL] [Abstract][Full Text] [Related]
39. Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line.
Christopher SA; Diegelman P; Porter CW; Kruger WD
Cancer Res; 2002 Nov; 62(22):6639-44. PubMed ID: 12438261
[TBL] [Abstract][Full Text] [Related]
40. Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro.
Batova A; Diccianni MB; Omura-Minamisawa M; Yu J; Carrera CJ; Bridgeman LJ; Kung FH; Pullen J; Amylon MD; Yu AL
Cancer Res; 1999 Apr; 59(7):1492-7. PubMed ID: 10197619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]